Alar Pharmaceuticals Inc. (TPEX:6785)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
156.00
+4.00 (2.63%)
Feb 17, 2025, 9:00 AM CST
-64.71%
Market Cap 10.09B
Revenue (ttm) 474.29M
Net Income (ttm) 400.72M
Shares Out 66.80M
EPS (ttm) 6.28
PE Ratio 24.03
Forward PE n/a
Dividend 1.50 (0.96%)
Ex-Dividend Date n/a
Volume 523,339
Average Volume 266,815
Open 146.00
Previous Close 152.00
Day's Range 146.00 - 163.00
52-Week Range 122.50 - 465.00
Beta 0.12
RSI 56.09
Earnings Date Mar 3, 2025

About Alar Pharmaceuticals

Alar Pharmaceuticals Inc., a drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan. The company develops ALA-1000 for the treatment of opioid use disorder. Its pre-clinical stage product includes ALA-1300 and ALA-2000 for the treatment of opioid use disorder; ALA-4000 to treat Parkinson’s disease; ALA-3000 for treating treatment-resistant depression; and ALA-5000 to treat schizophrenia. Alar Pharmaceuticals Inc. was founded in 2016 and is based in Taichung, Taiwan. [Read more]

Sector Healthcare
Founded 2016
Employees 22
Stock Exchange Taipei Exchange
Ticker Symbol 6785
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.